Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL828079

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C1N=C(c2ccncc2)Cc2ccc(N3CCOCC3)cc21

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RPS6KA3 P51812 2/20 0.39
RPS6KA2 Q15349 1/20 0.39
RPS6KA1 Q15418 1/20 0.39
ABHD6 Q9BV23 1/20 0.39
MAPT P10636 3/20 0.39
PLOD2 O00469 1/20 0.39
PLOD3 O60568 1/20 0.39
PLOD1 Q02809 1/20 0.39
AKR1C3 P42330 1/20 0.38
GSK3B P49841 2/20 0.38
CDK2 P24941 1/20 0.38
GPBAR1 Q8TDU6 1/20 0.38
PDK2 Q15119 1/20 0.37
HTT P42858 1/20 0.36
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4764401 0.73 MAPT (0.45) L3MBTL1RPS6KA3RPS6KA2MAPTLMNA
SCHEMBL341305 0.64 KIF11 (0.46) RPS6KA3RPS6KA2RPS6KA1MAPTCDK2
Trifluoroacetic Acid SCHEMBL6986818 0.64 CHKA (0.63) SLC2A1MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL8913999 0.62 MAPT (0.49) RPS6KA3RPS6KA2RPS6KA1MAPTPLOD2
SCHEMBL30628288 0.61 KMO (0.58) L3MBTL1NPSR1MAPTPLOD2PLOD3
SCHEMBL17420730 0.61 KMO (0.58) L3MBTL1NPSR1MAPTPLOD2PLOD3
SCHEMBL49166 0.61 CHKA (0.67) MAPTPLOD2PLOD3PLOD1HTT
SCHEMBL28241795 0.61 OGA (0.50) MAPTGSK3BKDM4EMEN1ALDH1A1
Trifluoroacetic Acid SCHEMBL3460138 0.60 L3MBTL1 (0.58) L3MBTL1PLOD2PLOD3PLOD1AKR1C3
SCHEMBL10386402 0.60 NPC1 (0.58) RPS6KA3RPS6KA2MAPTPDK2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724262-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-05-02 EP disclosed
US-8143274-B2 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-03-27 US disclosed
US-20070185160-A1 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-08-09 US disclosed
EP-1724262-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185160-A1 1-(2H)-isoquinolone derivative NR3C2, NR1H4, NR3C1 SLC2A1 1539/4885L3MBTL1 4073/4885NPSR1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.